The Data Story Behind the Image Webinar

Leveraging Radiomics Data in Drug Development and Commercial Strategies

Join your biopharma and life sciences colleagues to learn how novel radiomic data and integrated technology can be leveraged to support drug development pipelines, commercial strategies, and personalized health agendas. Hear how HealthMyne’s innovative AI and radiomic informed solutions are helping organizations:

• Digitize data from medical images

• Drive discovery, validation, and distribution of new imaging biomarkers

• Deliver real world evidence of therapy response

• Enhance existing clinical trials with new data

• Measure the impact on value-based outcomes
This webinar will discuss the hidden power and precision of radiomic imaging data as a bridge to personalized care- ensuring the right treatment every time.

About The Speakers:

Rose Higgins | Chief Executive Officer | HealthMyne

Rose brings a long and successful track record in executive management and leadership along with extensive experience in strategic sales and marketing, product development, project management and clinical practice to HealthMyne. Her prior work includes time with Cardinal Health (Pyxis), McKesson, and most recently she served as President of SCIO Health Analytics which was acquired by EXL Services.

John Pagliuca | Chief Growth Officer | HealthMyne

John has been responsible for leading revenue growth and commercialization efforts of emerging/advanced analytics and SaaS solutions into the Life Sciences vertical. He has more than 20 years of sales, marketing, and product experience, with expertise in evangelizing new offerings that drive value and outcomes across the healthcare ecosystem. Prior to joining HealthMyne John was the VP of Global Life Sciences at SCIO (acquired by EXL) responsible for building the Life Sciences analytics business.